MX2023012293A - Fragancia para mejorar el estado de estimulacion y metodo de evaluacion. - Google Patents

Fragancia para mejorar el estado de estimulacion y metodo de evaluacion.

Info

Publication number
MX2023012293A
MX2023012293A MX2023012293A MX2023012293A MX2023012293A MX 2023012293 A MX2023012293 A MX 2023012293A MX 2023012293 A MX2023012293 A MX 2023012293A MX 2023012293 A MX2023012293 A MX 2023012293A MX 2023012293 A MX2023012293 A MX 2023012293A
Authority
MX
Mexico
Prior art keywords
invigoration
state
fragrance
improving
assessing
Prior art date
Application number
MX2023012293A
Other languages
English (en)
Inventor
Alan Forbes Provan
Giuliano Gaeta
Natalie Anuradha T D Gunasekara
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of MX2023012293A publication Critical patent/MX2023012293A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/0036Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room including treatment, e.g., using an implantable medical device, ablating, ventilating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14553Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165Evaluating the state of mind, e.g. depression, anxiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4005Detecting, measuring or recording for evaluating the nervous system for evaluating the sensory system
    • A61B5/4011Evaluating olfaction, i.e. sense of smell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076Diagnosing or monitoring particular conditions of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0003Compounds of unspecified constitution defined by the chemical reaction for their preparation
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0061Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3306Optical measuring means
    • A61M2205/3313Optical measuring means used specific wavelengths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Social Psychology (AREA)
  • Educational Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Pain & Pain Management (AREA)
  • Acoustics & Sound (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)

Abstract

La presente invención se relaciona con métodos para evaluar la capacidad de un ingrediente de fragancia de prueba o una composición de fragancia de prueba para mejorar el estado de estimulación de un paciente humano y para crear composiciones de fragancia que tengan un efecto de activación positivo en un paciente humano. Se refiere además a composiciones de fragancias para mejorar el estado de estimulación de un paciente humano, a productos de consumo que comprenden tales composiciones de fragancias y a métodos para mejorar el estado de estimulación de un paciente humano.
MX2023012293A 2021-05-28 2022-05-30 Fragancia para mejorar el estado de estimulacion y metodo de evaluacion. MX2023012293A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2107716.9A GB202107716D0 (en) 2021-05-28 2021-05-28 Method
PCT/EP2022/064555 WO2022234151A1 (en) 2021-05-28 2022-05-30 Fragrance for improving invigoration state and method of assessing

Publications (1)

Publication Number Publication Date
MX2023012293A true MX2023012293A (es) 2023-10-26

Family

ID=76741227

Family Applications (6)

Application Number Title Priority Date Filing Date
MX2023012288A MX2023012288A (es) 2021-05-28 2022-05-30 Sabor para el cuidado bucal para mejorar el estado de estimulacion y metodo de evaluacion.
MX2023012292A MX2023012292A (es) 2021-05-28 2022-05-30 Sabor para el cuidado bucal para mejorar el estado de felicidad y metodo de evaluacion.
MX2023012295A MX2023012295A (es) 2021-05-28 2022-05-30 Fragancia para mejorar el estado de felicidad y metodo de evaluacion.
MX2023012297A MX2023012297A (es) 2021-05-28 2022-05-30 Fragancia para mejorar el estado de relajacion y metodo de evaluacion.
MX2023012293A MX2023012293A (es) 2021-05-28 2022-05-30 Fragancia para mejorar el estado de estimulacion y metodo de evaluacion.
MX2023012289A MX2023012289A (es) 2021-05-28 2022-05-30 Sabor para el cuidado oral para mejorar el estado de relajacion y metodo de evaluacion.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
MX2023012288A MX2023012288A (es) 2021-05-28 2022-05-30 Sabor para el cuidado bucal para mejorar el estado de estimulacion y metodo de evaluacion.
MX2023012292A MX2023012292A (es) 2021-05-28 2022-05-30 Sabor para el cuidado bucal para mejorar el estado de felicidad y metodo de evaluacion.
MX2023012295A MX2023012295A (es) 2021-05-28 2022-05-30 Fragancia para mejorar el estado de felicidad y metodo de evaluacion.
MX2023012297A MX2023012297A (es) 2021-05-28 2022-05-30 Fragancia para mejorar el estado de relajacion y metodo de evaluacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023012289A MX2023012289A (es) 2021-05-28 2022-05-30 Sabor para el cuidado oral para mejorar el estado de relajacion y metodo de evaluacion.

Country Status (10)

Country Link
US (5) US20240197221A1 (es)
EP (6) EP4347761A1 (es)
JP (1) JP2024521845A (es)
KR (6) KR20240017014A (es)
CN (6) CN117396589A (es)
BR (6) BR112023022697A2 (es)
GB (1) GB202107716D0 (es)
IL (6) IL308583A (es)
MX (6) MX2023012288A (es)
WO (6) WO2022234153A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031047D0 (en) 2000-12-20 2001-01-31 Quest Int Perfume compositions
US20080096790A1 (en) 2006-10-23 2008-04-24 Quest International Services B.V. Fragrance compositions
GB0621020D0 (en) 2006-10-23 2006-11-29 Quest Int Serv Bv Fragrance compositions
US8521243B2 (en) * 2007-01-17 2013-08-27 Hitachi, Ltd. Biological optical measurement instrument
GB201909221D0 (en) 2019-06-27 2019-08-14 Givaudan Sa Improvements in or relating to organic compounds
GB201909222D0 (en) 2019-06-27 2019-08-14 Givaudan Sa Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
US20240197183A1 (en) 2024-06-20
MX2023012292A (es) 2023-10-26
US20240197222A1 (en) 2024-06-20
KR20240016349A (ko) 2024-02-06
BR112023021833A2 (pt) 2023-12-19
EP4347758A1 (en) 2024-04-10
EP4347760A1 (en) 2024-04-10
BR112023022662A2 (pt) 2024-01-16
KR20240017016A (ko) 2024-02-06
CN117396590A (zh) 2024-01-12
US20240197221A1 (en) 2024-06-20
BR112023022696A2 (pt) 2024-01-16
CN117396591A (zh) 2024-01-12
EP4347762A1 (en) 2024-04-10
IL308588A (en) 2024-01-01
US20240197223A1 (en) 2024-06-20
MX2023012289A (es) 2023-10-26
KR20240017014A (ko) 2024-02-06
IL308586A (en) 2024-01-01
IL308580A (en) 2024-01-01
GB202107716D0 (en) 2021-07-14
WO2022234154A1 (en) 2022-11-10
BR112023022697A2 (pt) 2024-01-16
JP2024521845A (ja) 2024-06-04
US20240197243A1 (en) 2024-06-20
CN117396589A (zh) 2024-01-12
WO2022234150A1 (en) 2022-11-10
MX2023012295A (es) 2023-10-26
IL308583A (en) 2024-01-01
KR20240017013A (ko) 2024-02-06
WO2022234149A1 (en) 2022-11-10
EP4347761A1 (en) 2024-04-10
CN117396587A (zh) 2024-01-12
IL308579A (en) 2024-01-01
BR112023022702A2 (pt) 2024-01-16
MX2023012288A (es) 2023-10-26
KR20240016348A (ko) 2024-02-06
CN117396588A (zh) 2024-01-12
WO2022234151A1 (en) 2022-11-10
MX2023012297A (es) 2023-10-26
CN117480236A (zh) 2024-01-30
WO2022234152A1 (en) 2022-11-10
IL308584A (en) 2024-01-01
KR20240019173A (ko) 2024-02-14
EP4347759A1 (en) 2024-04-10
WO2022234153A1 (en) 2022-11-10
BR112023022663A2 (pt) 2024-01-16
EP4347757A1 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
MX2021006871A (es) Microcapsulas de poliamida.
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
MX2021006873A (es) Proceso para la preparacion de microcapsulas de poliamida.
WO2020165463A3 (en) Improvements in or relating to organic compounds
MX2011012728A (es) Composiciones que contrarrestan el mal olor y metodo de uso para contrarrestar el mal olor del sudor.
MX2017006545A (es) Proceso para la preparacion de 1-(2,6,6-trimetilciclohexil)-alcan- 3-oles.
MX2019002309A (es) Composiciones de fragancia.
MX2021011233A (es) Microcapsulas de poli(amida-ester).
MX2021008159A (es) Microcapsulas de poli(ester urea).
BR112019002199A2 (pt) composto, composição de aquecimento, composição aromatizante ou de fragrância, composição tópica, produto de consumo e método para melhorar, aperfeiçoar ou modificar as propriedades de sabor ou de odor de uma composição aromatizante ou de fragrância
MX2021011236A (es) Microcapsulas a base de multialcohol escindible.
MX2023012293A (es) Fragancia para mejorar el estado de estimulacion y metodo de evaluacion.
MX2017013278A (es) Odorante osmanthus.
MX2020011460A (es) Proceso de preparacion de microcapsulas a base de derivados de polisuccinimida.
MX2023013600A (es) Microcapsulas a base de poliamida.
MX2020006261A (es) Odorante aldehidico.
MX2023007048A (es) Composicion perfumante sinergica.
MX2023005949A (es) Composicion perfumante sinergica.
MX2018015570A (es) Composicion cosmetica anti-envejecimiento, uso de la composicion y metodo para tratamiento anti-envejecimiento.
MX2023013597A (es) Microcapsulas a base de poliamida.
MX2019002072A (es) Composiciones y metodo para la desactivacion de alergenos.
MY200966A (en) Composition For Recovering From Fatigue And/Or Preventing Fatigue Accumulation
MX2022010503A (es) Microcapsulas de poliamida.
MX2023009260A (es) Productos de consumo perfumantes antimicrobianos.